by Csequence | Jun 24, 2022 | Communications, Weekly Cannabis News
June 17th – June 24th, 2022 Cognitive Behavioral Therapy (CBT) to Stop Cannabis in First-Episode Psychosis (FEP) Patients Specific CBT treatments may be good interventional strategies to reduce cannabis use severity in FEB cannabis consumers, a new study suggests....
by Csequence | Jun 17, 2022 | Communications, Weekly Cannabis News
June 10th – June 17th, 2022 Effects of Cannabis Exposure on DNA Methylation in Sperm Cells Findings may provide a better understanding on the consequences of paternal cannabis use on DNA. Cannabis is the most widely illicit drug consumed in the US, with increasing use...
by Csequence | Jun 16, 2022 | Communications, Weekly Cannabis News
June 3rd – June 10th, 2022 Endocannabinoids & Post-Traumatic Stress Disorder (PTSD) Symptoms Treatment with endocannabinoids was associated with increased anxiety and general distress depression, a new study reports. According to the American Psychological...
by Csequence | Jun 15, 2022 | Communications, Weekly Cannabis News
May 27th – June 3rd, 2022 Cannabinoid Receptor 1 Blockade: A Novel Therapeutic Target to Treat Lower Urinary Tract Symptoms (LUTSs)? Administration of a CB1R antagonist decreased LUTSs in a mouse model of induced bladder dysfunction, a new study suggests. The...
by Csequence | Jun 14, 2022 | Communications, Weekly Cannabis News
May 20th – May 27th, 2022 Medical Cannabis Inhalers to Reduce Pain? Following medical cannabis inhalation, pain and opioid use were reduced while overall quality of life (QoL) was improved, a new study suggests. Medical cannabis has long been viewed as an alternative...
Some text her explaining our event planning services.
For more info, contact us:
events@csequence.com